n | in % | |||||
Low inaccurate (95% CI) | Low moderate (95% CI) | Accurate (95% CI) | High moderate (95% CI) | High inaccurate (95% CI) | ||
Phase 1 | ||||||
571 | Total | 11.6 (9.1 to 14.5) | 19.8 (16.6 to 23.3) | 23.6 (20.2 to 27.3) | 8.9 (6.7 to 11.6) | 36.1 (32.1 to 40.2) |
153 | Residents | 13.1 (8.2 to 19.5) | 17.6 (12.0 to 24.6) | 19.6 (13.6 to 26.8) | 10.5 (6.1 to 16.4) | 39.2 (31.4 to 47.4) |
418 | Oncologists | 11.0 (8.2 to 14.4) | 20.6 (16.8 to 24.8) | 25.1 (21.0 to 29.6) | 8.4 (5.9 to 11.5) | 34.9 (30.4 to 39.7) |
Residents vs Oncologists | p=0.902759232 | |||||
Phase 2 | ||||||
492 | Total | 8.9 (6.6 to 11.8) | 18.1 (14.8 to 21.8) | 26.6 (22.8 to 30.8) | 7.3 (5.2 to 10.0) | 39.0 (34.7 to 43.5) |
141 | Residents | 9.9 (5.5 to 16.1) | 23.4 (16.7 to 31.3) | 20.6 (14.2 to 28.2) | 5.7 (2.5 to 10.9) | 40.4 (32.3 to 49.0) |
351 | Oncologists | 8.5 (5.8 to 12.0) | 16.0 (12.3 to 20.2) | 29.1 (24.4 to 34.1) | 8.0 (5.4 to 11.3) | 38.5 (33.3 to 43.8) |
Residents vs Oncologists | p=0.55239201 | |||||
Phase 3 | ||||||
443 | Total | 5.0 (3.1 to 7.4) | 19.4 (15.8 to 23.4) | 28.0 (23.9 to 32.4) | 7.2 (5.0 to 10.0) | 40.4 (35.8 to 45.1) |
151 | Residents | 4.6 (1.9 to 9.3) | 19.9 (13.8 to 27.1) | 26.5 (19.6 to 34.3) | 7.3 (3.7 to 12.7) | 41.7 (33.8 to 50.0) |
292 | Oncologists | 5.1 (2.9 to 8.3) | 19.2 (14.8 to 24.2) | 28.8 (23.6 to 34.3) | 7.2 (4.5 to 10.8) | 39.7 (34.1 to 45.6) |
Residents vs Oncologists | p=0.999962755 | |||||
Total | ||||||
1506 | Total | 8.8 (7.4 to 10.3) | 19.1 (17.2 to 21.2) | 25.9 (23.7 to 28.2) | 7.9 (6.6 to 9.4) | 38.3 (35.8 to 40.8) |
445 | Residents | 9.2 (6.7 to 12.3) | 20.2 (16.6 to 24.3) | 22.2 (18.5 to 26.4) | 7.9 (5.5 to 10.8) | 40.4 (35.9 to 45.2) |
1061 | Oncologists | 8.6 (7.0 to 10.4) | 18.7 (16.4 to 21.1) | 27.4 (24.8 to 30.2) | 7.9 (6.4 to 9.7) | 37.4 (34.5 to 40.4) |
Residents vs Oncologists | p=0.997692477 |
No significant differences between phase 1 vs (2+3): total p<0.2; residents p<0.6; oncologists p<0.4.